Engineering neuroblastoma models for clinical translation
Neuroblastoma is a profoundly heterogenous extracranial solid tumor in pediatric patients. Elevated risk grade of neuroblastoma has been correlated with unsatisfactory prognosis and resistance to chemotherapy. Despite multimodal therapies exploited for killing neuroblastoma tumor cells, in high-risk...
Saved in:
Main Authors: | Taiyu Song, Rui Liu, Feika Bian, Bin Kong, Jingjing Gan |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2025-01-01
|
Series: | Engineered Regeneration |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666138125000088 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
POSTTREATMENT NEUROBLASTOMA MATURATION TO GANGLIONIC CELL TUMOR
by: M. V. Ryzhova, et al.
Published: (2015-04-01) -
Inhibition of Purine Metabolism Promotes the Differentiation of Neuroblastoma Driven by MYCN
by: Yufeng Jiang, et al.
Published: (2025-05-01) -
Tertiary lymphoid structures-driven immune infiltration patterns and their association with survival in neuroblastoma
by: Xuelian Liu, et al.
Published: (2025-07-01) -
Perinatal neuroblastoma: a case report of pepper syndrome
by: Bárbara Ribeiro Aguiar, et al.
Published: (2025-07-01) -
Surgical treatment of retroperitoneal neuroblastoma in children. Clinical experience
by: S. A. Kuznetsov, et al.
Published: (2022-03-01)